Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Oxalo Therapeutics | 2022 | Grant | $1000K | Chicago |
| PolyCore Therapeutics | 2022 | Seed | Undisclosed | Philadelphia |
| Dascena | 2022 | Grant | Undisclosed | Houston |
| Enspectra Health | 2022 | Grant | $1.2M | Menlo Park |
| Arc Bio LLC | 2022 | Grant | $1.9M | Menlo Park |
| Epitel | 2022 | Series A | $12.5M | Salt Lake City |
| Lightengale | 2022 | Grant | $50K | Decatur |
| HealthRhythms | 2022 | Seed | $11.0M | Long Island City |
| Anavasi Diagnostics | 2022 | Convertible Note | $6.0M | Seattle |
| Trace Matters | 2022 | Grant | $350K | Somerville |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 226 | Oxalo Therapeutics | Grant | $1000K | Chicago, United States |
| 227 | PolyCore Therapeutics | Seed | Undisclosed | Philadelphia, United States |
| 228 | Dascena | Grant | Undisclosed | Houston, United States |
| 229 | Enspectra Health | Grant | $1.2M | Menlo Park, United States |
| 230 | Arc Bio LLC | Grant | $1.9M | Menlo Park, United States |
| 231 | Epitel | Series A | $12.5M | Salt Lake City, United States |
| 232 | Lightengale | Grant | $50K | Decatur, United States |
| 233 | HealthRhythms | Seed | $11.0M | Long Island City, United States |
| 234 | Anavasi Diagnostics | Convertible Note | $6.0M | Seattle, United States |
| 235 | Trace Matters | Grant | $350K | Somerville, United States |
Oxalo Therapeutics creates drugs to treat rare kidney diseases and prevent recurring kidney stones.
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Dascena develops machine learning algorithms to enable early disease intervention and improve care outcomes for patients.
Enspectra Health is a digital transformation in pathology by imaging cellular anatomy.
Arc Bio provides research and development in the physical, engineering, and life sciences.
Epitel is empowering clinicians, patients, and caregivers who live with or care for neurological disorders with wearables and powerful AI.
Lightengale develops medical devices for improved ICU infusion lines.
HealthRhythms develops a mental health assessment and treatment platform to measure and monitor health conditions.
Anavasi Diagnostics is a medical technology company that focuses on the development of molecular diagnostic testing.
Trace Matters is a technology startup focused on developing next generation of mass spectrometry technologies for a variety of applications.
Bleep provides best new CPAP solution on the market.
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
4E Therapeutics is a neuroscience company that develops therapies for chronic neuropathic pain.
Biotechnology company inspired by globin chemistry and protein engineering focused on developing breakthrough antidotal therapies.
Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans.
dfusion, a team of scientists and innovators, develops technology to promote evidence-based, health-related behavioral changes.
Vibrato Medical is a medical device company developing wearable treatments for peripheral arterial disease.
Tabula Rasa enables medication optimization using its medication risk mitigation technology.
ID Genomics specializes in nucleotide sequence-based molecular diagnostics and epidemiologic analysis of microbial pathogens.
Cerecor discovers, develops and commercializes neuroscience drugs.
Xtrava is a developer of applications for health and wellness.
Quadrant Biosciences is an epigenetic diagnostics company focusing on the early detection of neurological disorders.
Visikol is a contract research organization focused on digital pathology, 3D tissue imaging and 3D cell culture assays and models.
Avexegen Therapeutics is a biotechnology company developing therapies for gastrointestinal disorders.
NeuraMedica is a medical device company developing a novel, bioabsorbable surgical clip to provide closure of the dura mater.
National Institutes of Health has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Medical Device. The firm invests across 32 different industry categories.
Among tracked funding rounds, CODA Biotherapeutics received $28.0M in a Series Unknown round. National Institutes of Health's total known invested capital is $1.3B.
National Institutes of Health's average investment size is $6.6M across its portfolio of 288 companies.
Recent National Institutes of Health portfolio additions include Oxalo Therapeutics, PolyCore Therapeutics, Dascena, Enspectra Health, Arc Bio LLC. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors